TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
OCS

Oculis Holding AG

Healthcare · Biotechnology

9.10$ -2.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement OCS
Line item 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% –
940.3% 996.7% 2,436.8% 3,312.2% 7,592.3% –
-840.3% -896.7% -2,336.8% -3,212.2% -7,492.3% –
940.3% 996.7% 2,436.8% 3,312.2% 7,592.3% –
354.0% 426.8% 739.4% 1,667.5% 3,178.9% –
1,242.3% 1,378.3% 3,550.0% 9,140.9% 3,178.9% –
-1,242.3% -1,378.3% -3,550.0% -9,140.9% -10,671.1% –
264.7% 533.3% 706.4% 165.7% 93.1% –
-1,489.4% -1,929.6% -4,237.2% -10,044.7% -12,527.3% –
8.4% 2.8% 6.0% 12.1% -23.3% –
-1,497.8% -1,932.5% -4,243.2% -10,056.9% -12,503.9% –
-1,218.2% -1,371.8% -3,498.0% -9,863.3% -12,468.1% –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?